ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000971.1|Cinnabaramide_1 # 1 # 1170 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000971.1|Cinnabaramide_1 	1	1170	+	Loose	350	27.335	vanO	40.0	3002913	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	CTGGGGAGAGAAAACCACTCGGGCGGGGCCATTGTCGCCCGTGAATCCACTGTATACAGTGTGTCCACTGCATCCAGAGAGGGGCTCCTGGCCATGTTCGTCCTCAACACCTGGTATGTCGCCGCATGGTCCGCCGAGGTGACCGCCAAGCCGGTGCGCCGGGTCATCTGCAAGCAGCCGATCGTGCTCTACCGCACCCCGGACGGCGGGGCGGTCGCCCTCGCCGACCGCTGCGCCCACCGGGCCTACCCCCTGTCCGAGGGCCGTACGGTCGGTGACTCGATCGAATGCGGTTACCACGGCTTCGCCTACGGCCCCGACGGCGCCTGCACCCGCGTGCCCGCCCAGTCCGCCATCCCGGCCCGAGCCCGGGTGCGCAGCTACCCGGTCGTGGAGAAGGACGGCTGGATCTGGGTCTGGACGGGAGAGCGGGAACTCGCGGACGAGAGCCTGGTCCCGGACACGCACTGGATGGACGACCCGGCGTGGGCCACGGTCACCCACACCGTGCTCTTCGAGTGCCGCCACGACCTCATCCACGACAACCTGCTGGACCTGACCCACGAGTCGTTCCTGCACCGGACGACCGTCGGCGACGACTACATCTACGAGCACGGCATCACGGTCGAGGTGGACGGCCGGGTCGTGACCGCCGACCGGCTGATGCCCGGCGTGCAGGCGCCGCCGCTGTATGCGCGGACCATGGCCGCCGAGGGCCTGTACGACCGGTTCCACGCCACCGAGTTCCACGTCCCGAGCTACCACGTGCTGCACTCCGGGATCACCGGCCAGGGCCGGCCGCGTGAGGAGGGCTACCTGATCAAGGTGCTCAACGGGATCACCCCGGTCGACGAGAAGACCACCTGGTACTACTACGCGTTCAGCCGGAACTTCGCCGTCGACGCCGAGTGGGCCACCGAGGAGCTCGAGGCCGGGCTCGCCACCGTGCTGCGGGAGGACGCCGACGCCCTGCGGGCCCAGGAGATCGGCATGCGGGACCGCCCCGAGACGGAGCACGACGTGCTCATCGGCCAGGACGCCGGCGTCGCCAAGGCCCGCCGGATCCTCTCCCGGCTCCTGGCGGCCGAGCAGCAGGCCGGTGGTCGGGCTCCCGAGGCGGACCGCTCCGCCCCGGCGTCCGGGACCGCGCCCGCCGCGGTGCGGGGCTGA	LGRENHSGGAIVARESTVYSVSTASREGLLAMFVLNTWYVAAWSAEVTAKPVRRVICKQPIVLYRTPDGGAVALADRCAHRAYPLSEGRTVGDSIECGYHGFAYGPDGACTRVPAQSAIPARARVRSYPVVEKDGWIWVWTGERELADESLVPDTHWMDDPAWATVTHTVLFECRHDLIHDNLLDLTHESFLHRTTVGDDYIYEHGITVEVDGRVVTADRLMPGVQAPPLYARTMAAEGLYDRFHATEFHVPSYHVLHSGITGQGRPREEGYLIKVLNGITPVDEKTTWYYYAFSRNFAVDAEWATEELEAGLATVLREDADALRAQEIGMRDRPETEHDVLIGQDAGVAKARRILSRLLAAEQQAGGRAPEADRSAPASGTAPAAVRG	MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWENRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYVGCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFGVSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGFFRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGRVVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR	112.43	gnl|BL_ORD_ID|1607|hsp_num:0	1754			891	1026	vancomycin
BGC0000971.1|Cinnabaramide_2 # 1501 # 1983 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.772	BGC0000971.1|Cinnabaramide_2 	1501	1983	+	Loose	300	26.5646	dfrA3	32.1	3003105	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGAGGCTTCTGCTCCGCGCCAACGCCCACCGGCACGTGGGCGGCGCCTGCTGGGAGGTCGCCGCGTCGCCGGACACGCCCCGGCGTGAGCGGTGGCAGTGGCAGGTGTGCCTGCTCGCCGGCGACCGGGGCCACGCCGACGCGCCGTCGCCCACGGCACTCCGGGTCGCCGCGCCCCTGCCCGGCGGGACGACCGTCGAGGTCGCGGCCGACCCGCTGACGGTCGCGCCCGCGGTCGAGGTCCTCGACCCCGGCTCCTCGCCCACGGTGGTGCGCACGGACGGCGAACTCGTGGTCCTGATCGCCTCGGGCGGGCGGGTGCTGGTCGAGGAGCGGCATCTGCTGGCCGACGCCGACGCGCTGGTGCTCGCGGGCGACGACCCGCTGGTCGTCGGCGTGCGCCGCCCGGACGGTTCGGACTCCCGACTCGCCGTGGTCCGTCTGGCACCCGTCCAGGACAGCGCCCTGAGCTGGGTGCCCTAG	MRLLLRANAHRHVGGACWEVAASPDTPRRERWQWQVCLLAGDRGHADAPSPTALRVAAPLPGGTTVEVAADPLTVAPAVEVLDPGSSPTVVRTDGELVVLIASGGRVLVEERHLLADADALVLAGDDPLVVGVRRPDGSDSRLAVVRLAPVQDSALSWVP	MLISLIAALAHNNLIGKDNLIPWHLPADLRHFKAVTLGKPVVMGRRTFESIGRPLPGRRNVVVSRNPQWQAEGVEVAPSLDAALALLTDCEEAMIIGGGQLYAEALPRADRLYLTYIDAQLNGDTHFPDYLSLGWQELERSTHPADDKNSYACEFVTLSRQR	98.77	gnl|BL_ORD_ID|470|hsp_num:0	511			138	369	trimethoprim
BGC0000971.1|Cinnabaramide_4 # 3183 # 4205 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.665	BGC0000971.1|Cinnabaramide_4 	3183	4205	+	Loose	400	25.409	Pseudomonas aeruginosa CpxR	26.83	3004054	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGACCAGAACGTGACGATCAGCAGCAGCGATTCGATCCTGGACGAGAACATGTATGACTTATACGGGTGGGTTCTGGAGAGGGGCTACTTCGACGACGGTCAGGCCGCCGAAGAACTCGGAGTCGAACTGAAGGAAGTCGTCAAGGCGTTCGAGCGGCTGATCCTGCTGGGCCTGATCCGGGTGGACCCGAGCAACAGGCTGCGCGCCCGGGCGGTCGACCCCGACGTCGCGTCGGTCCGCCACGTCCTTCCGCTGCACCACACGATCCGCCGCGAGCAGGAGAAACTGGACCGGTTGACCTCGGACTTCACCCGGTTGAGAGAAAGGTTTCTGAACCCCGTCAGGCTGAAGGACCCCAGTGGCAACCGCTGCCAGTCCTTCAAGGTCATACCCGACCTCGACGAGGTGCGCGCCGCCCTCAACCGGGCCGCGGCCGAGTGCCGTCAGGAGATGCTGACCATGCAGCCCGGCGGCAACCGTGCGCCCGAGGCGCTGGAGGAGGCCAGATCGCGAGACCACGCCCTCCTCTCACGTGGTGTCACCATGCGCACGCTCTACCATCACACGGCCCGCTTCAACGGCCCCAGTCTCGCGTACATGGACGAGGCCGTCTCCCGGGGCGCCGAATACCGCACCGCGCACGAACTCGTGGGACGCCTCGTGCTCTTCGACCGCACCAGGACGGCGTTCATCCCGATGGCGGACGACGAGGACGGAGCCGTCTGCATCAGCGAGCCCTCCGTCGTCGCCTACCTGCGGAAGGTCTTCGAAATGCTCTGGACGCGGGCCACGCCCCTCACGGGCGCCACGGCGGCCGATCTGGGGCAGGTGGCCAAGGAACTCGACGGCAGTATCCTCCAGTTGCTGGCCGCCGGGCTGAAGGACGAGGCCATCGCCCGACGCGTGGGCATGTCCCTGAGGACGACGCGCCGGCATATCGCCGACATCATGAAACAACTGGGCGCCGAAAGCCGGTTTCAGGCCGGGGTCCTCGCAGCCCGCGCCCAGGGTTTGATCTGA	MDQNVTISSSDSILDENMYDLYGWVLERGYFDDGQAAEELGVELKEVVKAFERLILLGLIRVDPSNRLRARAVDPDVASVRHVLPLHHTIRREQEKLDRLTSDFTRLRERFLNPVRLKDPSGNRCQSFKVIPDLDEVRAALNRAAAECRQEMLTMQPGGNRAPEALEEARSRDHALLSRGVTMRTLYHHTARFNGPSLAYMDEAVSRGAEYRTAHELVGRLVLFDRTRTAFIPMADDEDGAVCISEPSVVAYLRKVFEMLWTRATPLTGATAADLGQVAKELDGSILQLLAAGLKDEAIARRVGMSLRTTRRHIADIMKQLGAESRFQAGVLAARAQGLI	MSELLLIDDDRELCELLGTWLVQEGFSVRASHDGAQARRALAEQTPDAVVLDVMLPDGSGLELLKQLRGDHPDLPVLMLSARGEPLDRILGLELGADDYLAKPCDPRELTARLRAVLRRTHPAQPSAQMQLGDLSLNLTRGVAQIDGQEISLTLSESRILEALLRQPGEPLDKQALAQLALGRKLTLYDRSLDMHVSNLRKKLGSHPDGSPRILALRGRGYYYSH	151.11	gnl|BL_ORD_ID|2300|hsp_num:0	2685			537	660	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; panipenem; trimethoprim-sulfamethoxazole
BGC0000971.1|Cinnabaramide_5 # 4385 # 6157 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.728	BGC0000971.1|Cinnabaramide_5 	4385	6157	+	Loose	1000	37.3502	almE	26.04	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCACGGCCAGGCCGGAACCACATGCCGATTTCCTTACTCTTCCCGATGCCCTGCGGTACCGCAGCGAGCGACAGTCGCACAAGACCGCTTATGTCTTTCTGAAAGACGGCGAGGACGCCGAGGAGTCGCTGACCTACCGGGAACTCCACGAGGCGGCGTGCCGCCGGGCCGCGGCGCTCACCGCCGCGGGGCTCGCGGGCAGAAACGCCGTCCTCATGTACCCCTCCGGCCTGGAGTTCGTGCGGACGCTGCTCGGCTGCATGTACGGCCGGGTGGTGGGCGCCCCCGTCCAGCCGCCCCGTCGGCGCGCCGAGGTGGAGCGGCTGCGCCGGATCGCCGACGACGCCGGTACCGCGACCGTCCTGACGACGACCGAGGTCCTGCGCGACCTGCGCGAACGCTTCGGCGACCTGCCCGCCCTCGACGGGCTCGACCTCGTGGCCACCGACGACCCGGGCCTGCTGAGCACCGGCGAGGGCGGTGCGCCGGAGCGGTTTCCCGACCCCCGGGACATCGCGCTGCTCCAGTACACGTCCGGTTCCACCGGGCACCCCAAGGGCGTCATGGTCAGCCACGCCAACTTCCTCGCCAACGCGGTCGAGACCGACGCGCTCTGGCCGTGCGAGCCCGACGGGACCGTGGTCAACTGGCTTCCGCTCTTCCACGACATGGGAATGCTCTTCGGCGTCGTACTGCCGTTGTGGGCCGGCATTCCCTCGTACCTGATGGCCCCCGATTCCTTCGTCCGCCGTCCCGCCCGCTGGCTGGAGGCGATATCCAGATTCCGCGGCACCCACTCGGCCGCCCCGAGCTTCGCCTACGAACTCTGCGTGCGGGCCGCGGAGAACGGCATGACCGCCGGCGTGGGCGACCTGTCGAGCTGGCGGGTGGCCGCCAACGGAGCCGAGCCCGTGCGCTGGAGCACGGTCCGGGCCTTCACCGACACGTTCGCGCCCCACGGCTTCGACCCGCTCGCCATGTGCCCCGGCTACGGGCTCGCGGAGAACACGCTCAAGGCCACCGGCACCGGGGCGGATCGCGAGCCCGCGGTGCTGTGGCTGTCCGCCGAGGCACTCCGCGAGGGCAGGGCCCAGCCCGTCGGGGAGCGCGCCGACCGTGCCGTTCCGGTGGTCGGCAGCGGGCGCCCGGTCGCGGGCACGCGGATACGCATCGTGGACCCCGTCACCCGGCGGCCCCGGCCGCCGGGCCAGGTCGGGGAGGTCTGGATCTCCGGCCCGTGCGTCGCGGACGGCTACTGGGGCCGCCCCGCCGTCAGCGAGGAAACGTTCCGTGCCCGCGTCGCCGACGACCACGAGGACGCCGCCGGGGCCCCGCACCTGCGCACCGGCGACCTCGGTTTCCTGTACGGCGGCGACCTGTACATCACCGGGCGGATGAAGGACGTCATCGTCCGCAAGGGCCGCAACCACTACCCGCAGGACATCGAACTGTCCGCCGAACGCTCGGTGCCCGGGGTGCAGCCGAACGGTACGGCCGCCTTCTCGCTCGACGACGGGGAGCGCGAACGGCTGGTCGTGGTCGTCGAGGCCGACGGGCGGGTCCTGGGCGCCCTGGACGCCGAGACGCTCCGTGCGCGCGTACGCGACGCGGTACGGGCGGAACAGCGCATCACACCGGACGACGTCGTCGTCGTACGCCGCGGCAAGCTGCCGAAGACCTCCAGCGGCAAGGTGCAGCGGCAGGCGTGCCGCTCGCTCTACCAGGACGGCGCACTGACCCGCCTGGTCCCGTCCGCCCGGGAGGCGTGA	MTTARPEPHADFLTLPDALRYRSERQSHKTAYVFLKDGEDAEESLTYRELHEAACRRAAALTAAGLAGRNAVLMYPSGLEFVRTLLGCMYGRVVGAPVQPPRRRAEVERLRRIADDAGTATVLTTTEVLRDLRERFGDLPALDGLDLVATDDPGLLSTGEGGAPERFPDPRDIALLQYTSGSTGHPKGVMVSHANFLANAVETDALWPCEPDGTVVNWLPLFHDMGMLFGVVLPLWAGIPSYLMAPDSFVRRPARWLEAISRFRGTHSAAPSFAYELCVRAAENGMTAGVGDLSSWRVAANGAEPVRWSTVRAFTDTFAPHGFDPLAMCPGYGLAENTLKATGTGADREPAVLWLSAEALREGRAQPVGERADRAVPVVGSGRPVAGTRIRIVDPVTRRPRPPGQVGEVWISGPCVADGYWGRPAVSEETFRARVADDHEDAAGAPHLRTGDLGFLYGGDLYITGRMKDVIVRKGRNHYPQDIELSAERSVPGVQPNGTAAFSLDDGERERLVVVVEADGRVLGALDAETLRARVRDAVRAEQRITPDDVVVVRRGKLPKTSSGKVQRQACRSLYQDGALTRLVPSAREA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	106.12	gnl|BL_ORD_ID|4935|hsp_num:0	5928			555	840	colistin A; colistin B
BGC0000971.1|Cinnabaramide_6 # 6157 # 7152 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.747	BGC0000971.1|Cinnabaramide_6 	6157	7152	+	Loose	125	27.7202	vanXY gene in vanE cluster	32.2	3002967	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanXY	ATGGGGCGCCTTCGCGCCACCGCGGGTTCCGCCCACGCGAGGATCCAGGGCACCGGCGCGTACCGGCCGTCGCGGGTCGTGACCAACGACGAGATCTGCGCGCGCGTCGATTCGAGCGACGAGTGGATCCGCCGGCGTTCCGGCATCGTCACCCGGCACTTCGCCGGTCCCGACGAGACCGTCGTCACCATGGGGACGGAGGCGGCCCGCAAGGCGCTGGCCCAGGCCGGCACCGACCTGCGGGACGTGGGTCTCGTCCTGCTGGCCACGATGTCCTCGCTGGAGCAGTCGCCGGCCGTCGCCCCGCGCATCGCCCACCTGCTGGGGACCGACGCGGCGGCCGTGGACGTCGGCGCGGCCTGTTCGGGCTTCTCCTACGGACTGGCGCTGGCCGGTTCCGTCGTCCGTGCGGGCGACGCCCGGTTCGTCGTGGTCATCGGCTCGGAGCGGATGAGCGACATCGTCGATCCGGCGGACCGGGGCAGCGCGTTCCTCTTCGGCGACGGCGCCGGTGCCGTCGTCGTGGGCCCGTCCGAGACCCCCGGCCTCGGCCCGGTCGTCTGGGCGTCCGACGGGAACCAGCACCGGATGATCGCCCACGACCGCTCCTGGCTGGACACCCGTGACGGGTCCGGACCGTGGCCGACCTTGAGAATGGCCGGCCCGGAGGTGTTCCGCTGGGCGACCGGCACGGTCCCGGAGATCTCCCGTCGGGCGCTCGACGCGGCGGGGCTCGACGTCGCGGACCTCGCCGCCTTCATCCCCCACCAGGCCAACGCCCGGATCGTGGACTCCGCCGCCCGGTCCCTCGGCCTCGCCCCGCACACCGTGGTGGCCAGGGACGTCGTACGGGCGGGGAACACCTCGGCGGCCTCGATTCCGCTGGCCATGGACGCCCTGCTCGCCCAGGGCGGGCTCTCCCGCGGCGATCCGGCGCTGCTCGTGGGCTTCGGCGCGGGACTCACCTGCGCCGCCCAGGTGGTCGCCCTGCCCTGA	MGRLRATAGSAHARIQGTGAYRPSRVVTNDEICARVDSSDEWIRRRSGIVTRHFAGPDETVVTMGTEAARKALAQAGTDLRDVGLVLLATMSSLEQSPAVAPRIAHLLGTDAAAVDVGAACSGFSYGLALAGSVVRAGDARFVVVIGSERMSDIVDPADRGSAFLFGDGAGAVVVGPSETPGLGPVVWASDGNQHRMIAHDRSWLDTRDGSGPWPTLRMAGPEVFRWATGTVPEISRRALDAAGLDVADLAAFIPHQANARIVDSAARSLGLAPHTVVARDVVRAGNTSAASIPLAMDALLAQGGLSRGDPALLVGFGAGLTCAAQVVALP	MKKNYLRLINENNEIKDSERPSHLVQAPFAQTNILVDPMVAIQLEKLIKTTGLDSQIITIDGYRSKETQQALWDETIQEKGLEFAHKYVAKPGCSEHEIGLAVDLGLATKENDFIRPSFTDSPIVDKFLKHMTDFGFILRYQKGKESITNINYEPWHFRYVGTPHSSIMVQQNWVLEEYIEFIESIRGTAYEA	171.50	gnl|BL_ORD_ID|603|hsp_num:0	559			219	396	vancomycin
BGC0000971.1|Cinnabaramide_7 # 7317 # 8741 # 1 # ID=1_7;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=14bp;gc_cont=0.692	BGC0000971.1|Cinnabaramide_7 	7317	8741	+	Loose	700	28.8758	vanS gene in vanA cluster	25.0	3002931	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	TTGGAAGCCCTAGTGTTCACGCAATACGACCCCGAGTCCGCCGCGCTCACCGCCGGGCTGCGCGACCAGTTCGCGGAGTTCATGGCCGGAGAATGGGATGCGGAAAAACTGGCGGGCCACCAGAATCGCAAACTGCGCGAAACCGTCGAATACGTTCGCGTCAACTCCCCCTTCTACCGGCGGAAATTAGCCGGAATCACCGAGGAACAGGTCTCCGCGCTGCGCGTGGACGACTTGCGCGGCATTCCCTTCACGACCAAGGACGACCTGAGGAAGGCTCAGTTCGACATCCTCTCCCAGCCCGTCTCCAAGGCGTGGATCTTCTACGAGACCACCGGGACGACCGGCGCGGCGACACCGTGTCCGCGCACCAACGAGGATTCCATCCACAACAACACCGTCCTGACGGCGTACTACCACGACGTCCTGGCCGCCCATGGCGAGGAACAGGTCATCGGAGTCCTCGGACCGACCGAACTGCACGCCACCGGTGACACCTTCGGCGACGTCTGCCGCAATCTCGGCCACGCGGTGGCCAAGATGTGGCCGCACTCTCCCGTGATCGGGTTCGACCGCGCCCTGGAGGTCATGCGGTTGCTGTCGGTGACCGGGCTGTTCTGCACCCCCGGGATGGCCATGCGGCTCGCCCAGAAGGCCACCGAGGCGGGCCTGGACCCCCGTCGCGACTTCTCCGTCCGCGTCCTGATGCTCACCGGCGAACTAATGTCCCCCAGCCTCCTGGAGAACATCGGCGCGCTCTGGGGCGCCGAGGCGCGCAACGCCCTCTACGCCTCGCAGGAGGCGTCCGTGCTGGCGGCCGCCGCCTCGGACGGCGCGCTGCGCACCGCCCCGCTGATCAATCTCTACGAGGTGATCGACCCCGAGACCCTCGAACCGGTGGAGCCGGACCCCGACGGCGTCCGCTACGGCGAACTCGTCGTGACGAACCTCTACACCGGCGCCAAGCCGCTCGTGCGCTACCGCACCGGCGACCTCGTCAGGATGACCGACCCCGCGCCGGACGCGGCGGTGCCCGCGCCCTCGCTGCAGGCGGTCGGGCGGGTGGGCGACCGGCTGCTCCTCAACGGCCGGACCGTCAACGGCTACGACCTCGAAGACCTGCTGCTGCGCCGGTTCCGCTACCAGGACTACCAGGTCACCGTGGACCGCGACGAGGACGGCACCGACCGGCTCGCGCTCACCCTGCTCGCCGACCCCGACCGGGAGAGCGGCGCCGTCGAAGCGGCCGTCGAGGACTGCCGGGCGACGCTCGACACCCCCCTCACCGTCGGTTTCGGCACCCCTGGCCCCATCACCAGCACCGGGGCGATGGTCAGCTGGAAGGCCGCCCGCGTGGTCGACCTGCGCACCACGTCCTCGGACGAGCACGCCTCGGCCGTGCGCATCGCCGCGACGAGGGTCTGA	MEALVFTQYDPESAALTAGLRDQFAEFMAGEWDAEKLAGHQNRKLRETVEYVRVNSPFYRRKLAGITEEQVSALRVDDLRGIPFTTKDDLRKAQFDILSQPVSKAWIFYETTGTTGAATPCPRTNEDSIHNNTVLTAYYHDVLAAHGEEQVIGVLGPTELHATGDTFGDVCRNLGHAVAKMWPHSPVIGFDRALEVMRLLSVTGLFCTPGMAMRLAQKATEAGLDPRRDFSVRVLMLTGELMSPSLLENIGALWGAEARNALYASQEASVLAAAASDGALRTAPLINLYEVIDPETLEPVEPDPDGVRYGELVVTNLYTGAKPLVRYRTGDLVRMTDPAPDAAVPAPSLQAVGRVGDRLLLNGRTVNGYDLEDLLLRRFRYQDYQVTVDRDEDGTDRLALTLLADPDRESGAVEAAVEDCRATLDTPLTVGFGTPGPITSTGAMVSWKAARVVDLRTTSSDEHASAVRIAATRV	MVIKLKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVSIEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFRVELPAMPDLVDKRRS	123.44	gnl|BL_ORD_ID|1809|hsp_num:0	1907			633	843	vancomycin; teicoplanin
BGC0000971.1|Cinnabaramide_8 # 8741 # 9736 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.732	BGC0000971.1|Cinnabaramide_8 	8741	9736	+	Loose	650	29.261	tetA(58)	34.09	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGGCCCCAGGACAGCGCGACCCTCATCCGTCCGGCGCTCGGACTGGGTGCGTGGGCGTACGACCGGGGCGAGTTCGTCCCGGCCACCGCCCCACGACTGCCGCTGTCGACCCAGGGCCTGCACTACGGGACGGGCGCCTTCGAGGGGATCCGCGCCCACCGCTCGGACGCCGGCGTCTTCCTGTTCCGGGCGCACGACCACTACCAACGCCTGCTGCGCGCCTGCCGGCTCCTGCGCATCACCGGCATCCGGCACGACGCGGGCGAACTCGTCGACCTCACCGTCGAACTGCTGCGGCGCAACGCCCACGACACGGACGCCTACGTGCGGCCCGTGGCGTACAAGCTCTCCCTGCTGCCGGGCACCCCACCGGGCGTCTCGCTGCGCGGCGTCTCCGACGCGCTGTCCATCACCACCTTCGGTTTCCCCCAGACCAGGGCCGCGGACGGAGTGCGCGCCGTCCTCAGCGGCTGGCGGCGTCCGGCCGGCGACAGCCTGCCCGCCCAGGCCAAGATCACCGGCGGCTACGCCACCACCGCCCTCGCCTGCGACGAGGCACGGGCGTCCGGCTACGACGACGCCATCCTCCTGGACCGCGCGGGAAACGTCGCCGAGGCGACCACCGCCAACGTCTTCGCGGTCATCGGCGGCACCCTGGTCACCCCGCCCGACACCGGCGACCTCCTGCCCGGCATCACCAGGGACACCCTCATCACCCTCTGCCGGGAGGCCGGCACGGAGGTCCGGGAACGGGTGCTGCGCCCCGCGGACCTGTTCACCGCCGACGAGGTGTTCCTCTCCTCCACCGGGAACGGGGTGGTCCCCGTGACCTCCCTCTCCGGCAGGGACGTGGGGACGGGCGCCGTCGGCCCGGTCACGACCCGGGTCCGCGAGCTGTACACCGAGGCCGTGAGTTCCCCGGGCGGAGCCCATCCGGAGTGGCTCACGCCCGTCTCCTCCCATGCAACGCCGACCTCAGGGAAACAAGGATGA	MGPQDSATLIRPALGLGAWAYDRGEFVPATAPRLPLSTQGLHYGTGAFEGIRAHRSDAGVFLFRAHDHYQRLLRACRLLRITGIRHDAGELVDLTVELLRRNAHDTDAYVRPVAYKLSLLPGTPPGVSLRGVSDALSITTFGFPQTRAADGVRAVLSGWRRPAGDSLPAQAKITGGYATTALACDEARASGYDDAILLDRAGNVAEATTANVFAVIGGTLVTPPDTGDLLPGITRDTLITLCREAGTEVRERVLRPADLFTADEVFLSSTGNGVVPVTSLSGRDVGTGAVGPVTTRVRELYTEAVSSPGGAHPEWLTPVSSHATPTSGKQG	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	96.50	gnl|BL_ORD_ID|2243|hsp_num:0	2517			744	972	tetracycline
BGC0000971.1|Cinnabaramide_9 # 9733 # 10350 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000971.1|Cinnabaramide_9 	9733	10350	+	Loose	400	24.2534	IMP-27	36.67	3002218	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGACGCTCCTCAGCTTCGACACCCTCCTGCGTCCCGGCTCGGACGACGTCGTCTCCGTGGGCACCTTGGGCCCGACCGGGACGAGCAGCGAGGTGGCCGCCGCCCAGTTCGCGCGCCGGGTCGCCGGGGCCGGCGACCCGCCCGCCGCCGTGCACCTGTTCGACACCTACGAGGAGGCCGCCGACGCGCTGCGCGAGAACGCCGTGACCCATGTCGTGGTCGCCAACGCCTACAAGGCGGTCCACCACTTCTACATGGACCCGGCCCTCGAACTGACCAACGTGTTCGTGATGGACACCCCGCTCTACGGCATCGCCGCCCGCGAAGGGGCCGTACCCGTCACCGACTCCCCGACCGTCGCCAGCCACCCCTCGCCCGAACCGATCATCGCCCAGCTCATGCCGGCCCGGCACACCACCTACAAGGTGCTGTACGCGGACTCGACCAGCGCCGCCGCGCTCGCCGTCCAGGACGGGACCGCCGACCTCGCCCTCACCACCGTGCCCGCCGCCGAGCGGTACGGGCTGACGTTCATCACGGGCAAGCGGCCCATCCGCATGGTCTGGTCCGTGTTCACCAAGGCCGGCCGGGCCGGCTCCACCGGCCCGGCCGTCTGA	MTLLSFDTLLRPGSDDVVSVGTLGPTGTSSEVAAAQFARRVAGAGDPPAAVHLFDTYEEAADALRENAVTHVVVANAYKAVHHFYMDPALELTNVFVMDTPLYGIAAREGAVPVTDSPTVASHPSPEPIIAQLMPARHTTYKVLYADSTSAAALAVQDGTADLALTTVPAAERYGLTFITGKRPIRMVWSVFTKAGRAGSTGPAV	MKKLFVLCVFVFCSITVAGETLPNLRVEKLEEGVYVHTSYEEVKGWGVVTKHGLVVLIGADAYLIDTPFTAKDTEKLVNWFVERGYKIKGTVSSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFDGVSYWLAKDKIEVFYPGPGHTQDNVVVWLPEKEILFGGCFVKPHGLGNLGDANLEAWPESAKILMEKYGKAKLVVSGHSETGDATHLKRTWEQAVKGLKESKKTLQPSN	83.33	gnl|BL_ORD_ID|1848|hsp_num:0	2006			633	723	
BGC0000971.1|Cinnabaramide_10 # 10384 # 11373 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.752	BGC0000971.1|Cinnabaramide_10 	10384	11373	+	Loose	580	25.0238	SHV-218	30.23	3005238	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGCTGCTGCTCGACGGCGACCAGGTGCGCCAGGTCTTCCCGGCGGCCGACGCGTACCGGGTGGTGGCCGACGTGATGCGCCGCTACAGCGCGGGCGACGTCGTCCAACCGGTGCGCACGGTGCTCGGCTCGGGCCACGACTCCTCGCTCCTCGCGGCCATGCCGTGCCACGTCACCGGGGAGACCGACTCGGGCTACGGCCTCAAGGCGGTGCTGCACGTCCCCGGCAACACGGAGCGCGGCCTGCCGACCCATGTGGGGGTGGTCGTGGTGTTCGACCCGCAGACCGGCCGGCCGCTGGCCATGATGGACGCCGCGGCGGTCACCGCGCTGCGTACCGCCGCCGCGTCCGCCGTGGCGACCGACGTCCTGGCCCGGCCCGACGCCGGGGACCTCGCCCTGATCGGTGCCGGTGCCCAGGCCCGCGGCCACCTGCTGGCGCTCGGTGAGATCCGCGCACTGCGCCGGGTCCGGCTGTGGAACCGCGGCGCCGAGCGGGCCGCCGCGTTCGTGGCCTGGGCGCGGACCCGGACCGGCGTGGACGTCGAACTCGTGGACACCCCCGCCGACGCGCTGCGCGGCGCCGACCTGGTCTGCACGACCATCGACACGACCGAACCCGTCGTACGGGCGGCCGACCTCGCCGAAGGCGTCCACGTCAACGCCGTCGGCTCCTCGGTACCGGGCCGGCGCGAACTCGACGCGACCGCCGTCGCGGCCTGCTCCGTCTTCGTGGACAGCAGGGAGGGCGCTCTGCGGGAGTCCTCCGAGATCGCCTCCCCGGTCGAGGCGGGACTGGTCCCCGCCGACCGGCACCTGCCCGAGATCGGCGAGGTGCTGCTCGGCAAGCACGCCGGCCGTACCGCCCCCGGGGAACGCACCCTCTACAAGTCGCTGGGCATGGCCGCCCAGGACGTCGCCTCCGGGTTCGCCGTCGTACGCGCCGCCCGGAGCCTCGGAGTGGGCACCGAGACCGCCTTCAGCTGCTGA	MLLLDGDQVRQVFPAADAYRVVADVMRRYSAGDVVQPVRTVLGSGHDSSLLAAMPCHVTGETDSGYGLKAVLHVPGNTERGLPTHVGVVVVFDPQTGRPLAMMDAAAVTALRTAAASAVATDVLARPDAGDLALIGAGAQARGHLLALGEIRALRRVRLWNRGAERAAAFVAWARTRTGVDVELVDTPADALRGADLVCTTIDTTEPVVRAADLAEGVHVNAVGSSVPGRRELDATAVAACSVFVDSREGALRESSEIASPVEAGLVPADRHLPEIGEVLLGKHAGRTAPGERTLYKSLGMAAQDVASGFAVVRAARSLGVGTETAFSC	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDPASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATFGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	115.03	gnl|BL_ORD_ID|2946|hsp_num:0	3960			27	261	
BGC0000971.1|Cinnabaramide_11 # 11417 # 11704 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.663	BGC0000971.1|Cinnabaramide_11 	11417	11704	+	Loose	1000	22.7126	MCR-6.1	47.62	3004501	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGACGGCACTACTGATCGGCAACGTCGGCGTGATCGGCGACGAGCGGGCCATGGCGGAGTACCGCGAGAAAGTGCTCCACACCCTCGAACTGTACGGCGGCGGATTCATGATCCGCGGCGGCGCGTTCGAGACGCTCGAAGGCGACTGGAACCCCACGCACCTGTCGGTGATGGTGTTCCCCACGGCCCATCTCGCCCGCCTCTGGTACACCTCGCCCGAGTACCAGGCCATCGTCCCGCTGCGCGCGGGCACCCACATGGACCTGGTTCTGGTGGAGGGCGAATGA	MTALLIGNVGVIGDERAMAEYREKVLHTLELYGGGFMIRGGAFETLEGDWNPTHLSVMVFPTAHLARLWYTSPEYQAIVPLRAGTHMDLVLVEGE	MTQHSPWYRRPVNPYLLMSVVALFLSATANLTFFDKITNTYPMAQNAGFVISTALVLFGAMLLITVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAESKDLMNMAFFVRIIGLGVLPSILVAWVKVDYPTLGKSLIQRAMTWGVAVVMALVPILAFSSHYASFFREHKPLRSYVNPVMPIYSVGKLASIEYKKATAPKDTIYHAKDAVQTTTPAERKPRLVVFVVGETARADHVQFNGYSRETFPQLAKIDNLANFSQVTSCGTSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVGILWRDNNSDSKGVMDKLPASQYFDYKSATNNTICNTNPYNECRDVGMLVGLDDYVSTNQGKDMLIMLHQMGNHGPAYFKRYDEQFAKYTPVCEGNELAKCEHQSLINAYDNALLATDDFIAKSIDWLKTHQANYDVAMLYVSDHGESLGENGVYLHGMPNAFAPKEQRAVPAFFWSNNPSFTPTASDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR	17.66	gnl|BL_ORD_ID|2664|hsp_num:0	3129			909	972	colistin A; colistin B
BGC0000971.1|Cinnabaramide_12 # 11701 # 12543 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.747	BGC0000971.1|Cinnabaramide_12 	11701	12543	+	Loose	600	25.409	LMB-1	30.23	3005018	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	LMB beta-lactamase	ATGAGCCCCAGGGAACGTCCCTTCGCCCAGGTCGACGTGTTCTCGGACACCCGCTACCTGGGCAATCCCGTCGCGGTCGTCCTCGACGGCGACGGGGTCGACGAACGGGACATGGCCCGCCTCGCGGCGTGGACCAACCTCTCCGAGACGACCTTCGTCGTCCCGCCTTCCTCCGGCGAGGCCGACTACGCGCTGCGCGTCTTCACCCCCGGCGGGGAGATCCCGTTCGCCGGCCATCCCACCCTGGGCACCGCCCACGCCTGGCTGGAGGCCGGCGGCGTACCGAAGTCGCCCGGGACGGTCGTCCAGGAGTGCGGCGCCGGCCTGGTCGCGGTGCGGCGTTCGGCTTCCGGGCTCGGCTTCCGGGCTCCTCGACCGCGGCGCACCGGCCCGCTGGACGCGGACCACGTCGACCGGATAGCGCGGGCACTGCGCGTCGGCCGCGAGCGCATCGTCGCACACCAGTGGGTCGACAACGGCCCCGGCTGGGCCGCCGTACGCCTCGCGTCGGCGGCGGAGGTCCTCGCCCTGGAACCGGACGACCACCACCTGCGCCGGCTGATGCTCGGCGTCGTCGGCCCCCATCCGCCGGGCTCACCGCTGAGCTTCGAGGTCCGCGCCTTCGGCCTGCCGGCCGGGGTGCGCGAGGACCCGGTGACCGGAAGCCTGCACGCGGGCCTCGCCCAGTGGCTGATCGGCGACGGCACCGCCCCGCCCGCCTACCGCGCCGGCCAGGGCGCCCGCCTGGGACGCCACGGTGTCGTCGCTGTGGAGACCCAGGGCGAGGACATCTGGATCAGCGGCGAGAGCGTCACCTGCGTACGCGGCACCGTGCACCTGTGA	MSPRERPFAQVDVFSDTRYLGNPVAVVLDGDGVDERDMARLAAWTNLSETTFVVPPSSGEADYALRVFTPGGEIPFAGHPTLGTAHAWLEAGGVPKSPGTVVQECGAGLVAVRRSASGLGFRAPRPRRTGPLDADHVDRIARALRVGRERIVAHQWVDNGPGWAAVRLASAAEVLALEPDDHHLRRLMLGVVGPHPPGSPLSFEVRAFGLPAGVREDPVTGSLHAGLAQWLIGDGTAPPAYRAGQGARLGRHGVVAVETQGEDIWISGESVTCVRGTVHL	MTLAKSFRCFCLVTTLSSMAMLAGCGGTAPVTVLSPPPADWVNSCKDWDDWDKAGPPYRIYGNSYYVGTCGISAILITGDNGHILIDGATEAGAKVIAANIDRLGFSLRDVKLLLQSHEHFDHVAGLAQLQQQSGAKLLASPAAAPVLTSGVVAAADPQAGMHEPFPAVRVDGLVTAGQVVTLGKLSLLPVATPGHTPGALSWQWSSCEAGQCQVLVYADSLSPVSSDSYRFSEHLTYLNAYRASLHKLAALDCQILLTPHPSASNMRTRLQSSAGLTDTQGCVVYADAITQRLEQRLIKETTQ	92.11	gnl|BL_ORD_ID|2750|hsp_num:0	3761			291	420	
BGC0000971.1|Cinnabaramide_14 # 14213 # 14410 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=14bp;gc_cont=0.702	BGC0000971.1|Cinnabaramide_14 	14213	14410	+	Loose	650	24.2534	TriA	25.0	3003679	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGGATCGACATCGACAAGGACAGGTGCCTGGGGTCCGGGCAGTGCCGGCAGTACGCGCCGGAGGTCTTCGACCAGGACGAGGACGACGCCCTGGTGACGCTGCTGGACGCGGTGCCGCCGCAGGAGTTCCACGACGCCGTCCGGGACGCCGCCATGCTCTGCCCCGGCGCGGTGATCACGCTCCACGAAGGCTGA	MRIDIDKDRCLGSGQCRQYAPEVFDQDEDDALVTLLDAVPPQEFHDAVRDAAMLCPGAVITLHEG	MSDARGAFHSKGRWSRMALPAILCAGLLVGCGAEPPAEEHVRVLAQTVKMAEFASATSITGDIQARVQADQSFRVGGKIVERLVDVGDHVAAGQVLARLDPQDQRSNVENAQAAVAAQQAQSKLADLNYQRQKALLPKGYTSQSEYDQALASVRSAQSSLKAAQAQLANARDLLSYTELRASDAGVITARQAEVGQVVQATVPIFTLARDGERDAVFNVYESLFSHDVDGQRITVSLLGKPEVTASGKVREITPTVDERSGTLKVKVGLDSVPAEMSLGSVVNASVAAPAEHSVVLPWSALSKVGEQPAVWLLDQQGKARLQPVRVARYASEKVVIDGGLEAGQTVVTVGGQLLHPGQVVEVAQPPQPTQSTASRDAVGGGQP	16.97	gnl|BL_ORD_ID|2002|hsp_num:0	2192			711	867	triclosan
BGC0000971.1|Cinnabaramide_16 # 15702 # 21695 # 1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=CGA;rbs_spacer=13bp;gc_cont=0.740	BGC0000971.1|Cinnabaramide_16 	15702	21695	+	Loose	275	28.8758	AAC(6')-Ix	33.33	3002568	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	TTGCACAGCTCGGGCCTGGACTCGGCGAAGGCCGTCCAGCTCGTCACCGCGCTGTCGGAGTTCCTCGGCCGGCCGGTCCCGGTCACCGCCCTGTGGGACCATCCGACCCCCGAGGCACTGTGCCGCGCCCTGGCCGGGGACCCGCAGGACGAGGACACGGGAGGGGGCCGGACGCGGCGCGGGTACGACCCGCAGGAGCCGGTCGCCCTCGTGGGCATCGGCTGCCGGTTCCCCGGAGCGCCGGACCCGGAGTCGTACTGGCGGCTGCTCGTCGAGGGGCGGGACGCCGTCGACGTGGTGCCCCCGGTACGCCGGGAGCGCATCGGGCCCGATGACGTCGCGCCCTCGTTCCGCTGGGGCGGGCACCTCGACGACATCGACCTGTTCGACCCCCTGTTCTTCGGGATCTCCCCCCGCGAAGCCGTCGCCATGGACCCCCAGCAACGGCTGGTGCTGGAGCTCGGCTGGGAGGCACTGGAGGACGCCGGCATCCCGCCGCGCAGCCTCGCCGGGAGCGACACCGGCGTCTTCATGGGATCGAGCTGGAGCGACTACGCCGCGCTGGCGCACCGGTCCGCAACCCAGGAGGACATCGGGCCGCACACCGCGACCGGGACGCAGGACAGCATCATCGCGGGCCGCCTCTCCTACGTGCTGGGGCTGCAAGGGCCCAGCATGGCCGTCGACACGGCCTGTTCGTCCTCGCTCGTCGCGGTCCACCTCGCCTGCCAGTCGATCCGCGGCGGCGAGAGCGAACTGGCCCTGGCCGGCGGGGTCAACCTGAGCTTCCTCACCGAGCACTTCCTGGCCATGGACCGGCTCGGCGCGCTCTCGTCCGACGGCCGCATCAAGGCCTTCGACGCCCGTGCCGACGGCGCCGTCCGCTCGGAGGGCGCGGCCGTGGTCGTCCTCGCCCCGCTGCGGACGGCCCTCGAACGCGGACTGCCCGTGTACTGCGTCATCCGCGGCAGCGCCGTCAACAACGACGGTCTGAGCAACGGCCTCACCGCCCCCAACCCCCGCGCCCAGGAAGCACTGCTGCGCACCGCCTACCGGCGCTCCGGCATCGCCCCGGAGCTGGTGGACTACGTGGAGTGCCACGGCACGGGCACCCCGCTCGGCGACCCGATCGAGGCGAAGGCCCTCGGGACCGTCCTCGGCCAAGGACGCGACCCCGGCGACCCCCTGCGGATCGGCTCGGTGAAGACGAACCTGGGACACCTGGAACCGGCGGCCGGCATCGCCGGCCTGGTCAAGGTGGCGCTGGCCCTGCGCAACGGCGTCCTTCCGGCCAGCCTGCACTACACCAGCCCCAACCCCCGCATCCCCTTCGCCGAGGCGGGGCTGCGCGTCCAGGACCGGACCGCCCCCTGGCCCCGCAGAGCGGACGGACGCCGGGCCGGCGTCAGCGCCTTCGGCTTCGGCGGCACCAACTGCCACGTCGTCACCGAGGAGTTACCGCGGCCCGAGGCCTCGTTGCTGCTGCTGAGCGAGGACTCCCGGCAGGCACTCGACGACCGGGTCGCCGAACTGGCCGCCGACCTCGCGGACGGCACCGGCACCCACCTGCCCGCCCTGTGCCGGGAGGCGCTCGACACCCGCGGCACCGGCCCCTTCAGGCTGGCCGCGACCGCCGCCGACCGCGACGAACTGCGGGCGCAACTGGCGGCGTTCACCGCCGAACGCGACCACGCGGGACTGGTCCACCGCGAGACCGGCACCCGCCCGCCCCGTGTGGCGTTCCTGTTCTCCGGCACCGGCAGCCAGTGGCTCGGCATGGGCAGGCGGCTGCTGGCCGGGATGCCCGCCTTCCGCACGTCCCTGACCCGCGTCGACGCACGGATCCGGGAGGTGGCCGACTTCTCCGTCCTCGACGAGCTGCTGGCGGGACCGGACCGGGCCCGGCTCGACGACATGGAAGTCGTCCAACCCGTCCTGTTCGCCGTGCAGATCGCCCTCGCGGACGCGTGGCGCTCCCTGGGCGTGGTGCCCGACGTCGTCCTCGGGCAGAGCATCGGCGAGTTCGCCGCGGCCCATGTCGCCGGGGCGCTCGGCCTCGACGACGCCGTCCGGCTGGCCGTGCACCACGCGCGGCTCGTGCAGCGCCACGCCGTCGGTCTCGGGGACGCGATGGTGGTGGACTGCGACGAGACCCGCCTGGCACCCCACCTCGCGGCCCTCGCGGACCACGTCACCCTCGCCGGGCGCAACAGCCCCGGCTCCGTGCTGGTCTCCGGCGACGGCACCCGGCTGAGGGAACTGGCCGCACGGCTCACGGCCGACGGCGTGACCAGCCACCCGGTCCGGATGGGATACGCCGCCCACTCGCCCCTCGTGGAAGCCGTCGTGGCCCCGCTGCGGACCGCACTCGCCGGGATCACGCCCGCCGAGCCCAGGATCCCCATGATCTCCACCGTCACCGGCGAGCGGATCACCGGTGAGACCGTGGTCGGCCCCGACTACTGGGCACGCAACGTGCGCGGCGAGAGCCGGCTGCTCGACGCCCTGCTGACGACGGCCGACCACGGGGTCGACGCGATGATCGAGATCAGCCCGCACCCGGTGCTGCTCAAACCGGTCCGCGAGACCCTCGCCGACCGGCCGATCAGCTGCCTTCCCTCGATGCGCCGCGGCACCGACGACGCCCGTAGCCTGCTCTCCTCCCTCGGGGAACTGCACGCCGCCGGACTGACCGTCGCCGCCGACTCGTTCCTCGTCGGCGACCGGGGACGGCACGTCACGCCCGTGCGGCGCGGCGCGCCCACCCGCGCCGTCCCCGAGCCCGAGCCCGCTGATACCCACCTCGTACCGGTGACCGCCCACTCGGCCGACGCCCTGCTGGACACCTGCCGGGCGCTGTCCCGGCACGTCGAGCGGGACACCGGCCTCACCGTCCCCGACCTCGCCCACACCCTCGCGGCCCGGCGCAGCCACCACCGGCACCGCGTCGCGATCCTCGCGGGCGGACGCCAGGAGCTCCTCGACACACTCGCCCGGGTCGCCACGGGCGAACCCGACCCCGCCGTCCTGCGGGGCGCCACCGCGGACGGCGACCACCGGAGGGTCGCGTTCGTCTTCTCGGGGAGCGCCACCCAGTGGCCGGGCATGGGACGCGAACTCCTGAAGCGGCACGCCGGGTTCGGCGCCGCCATGGAGGAGTGCGACGCCGCGGTGCGCGAGGTGGCCGGCTGGTCCGTGCTGGAGGAGCTCCTGGCGCCTGCCGAGACGTCCCGGCTGCACGAGGGGGACATCCAGCAGCCGGTGCTGTTCGCCCTGCACGTGTCCCTCGCCCGGCTCTGGACGGACCTCGGCGTACGGCCCGCCGCGCTCGTCGGACACAGTCTCGGCGAGGTGGCCGCGGCCTGCGTGGGCGGCGCGCTGTCCCTCGAGGACGGCGCCCGCATCGCCGTGGCCCGCTCCCGCCTCATCCAGCACGAGGTCGGCCCCGGCGCCATGATCGTCGCCGAGCAGTCGCCGGAGCTGTCCGCCTGTCTCGCCCGCTACGAGGGCGAGGTGTCCGTCGCGGCCTACAACAGCCCGACCGGCGTGGCCCTCTCCGGCACACCGGAGGCGATCCGCGCCCTGGAGGCGGACCTGAAGCGGGCCGGACTGTCCAGCCGTGCGCTCCGAGTGGAGCGAGCCGGACACAGCGTGCTCATGGAGCCGGTCCTGCCGGCCCTGCGGGCGGAGCTGAAGGACATCACCCCCCGGCCCTTCCGGGTGCCGCTGCGCTCCACCGCCCTCGACGCAGTGGTGAACCCGCGGGTCGACGCCGACTACTGGGTGCGCAACCTCCGCGAGCCGGTCCGGTTCTCCCAGGCCGTCGCGGCGCTGGTCGAGGACGGCATCGACACCTACGTCGAAATAGGTCCGCACGGCACCCTGCGCGGTGCCATCGAGGAGACCGCGCTGTCCCGGGGCGCCTCCGTGCACGTGGTCGACTCGCTGCGCCGCGGGCAGAGCGACGTCCGCTCCGTTCTGGGCTCGGTCGCCTCCCTCTTCACCCACGGCGTGCCCCTGACCTGGGACACGCTGTACCCGGCCGGCGCACAGGCGGTCGAGACCCCCCTGGTGCGCTGGCAGAAGCAGCGGTACTGGCTGGGCACGACCGCGGCGCCGCGCGAGCGGGGCGCCGACGTCGGCGCCGCCCCCGGCGCCGCCGTCGAGGAGCCCGCCGTGCCCACCGGGTCGCGGGAACCCCGTGACGTCGTCCTCGGTGAGATCGCCGAGATGCTCGCCGTCCCGGCCGACCTGCTCGGCCCCACCGCCCGGCTCCAGGACTTCGGTCTGGACTCCATGCTCGCGATCCGGCTCACCAACAGGATGCAGACGCTCTTCGGCCACCGTGTGTCACCGGTGGAGTTCCTCAAGGGCGGCACGGTCGGCGAACTCCTCGACCGGGTCCTCACGCTCGTCGCGCCGCGGTCCGAGACCCCTCGGCCCGGGACGGCACCGGACGACGCCGACCCGCGGCCTGCGCACCTCACGGACGACGACGCGGCGGAGCTCCTCGACGAACTCGTCGCCCGCGGGCTCCTCGCACCCGCGGAGGACGGCACCCCCGCGTCCGAGGCCCTGCGCACCGCCCTGGAGAAGGACCGGACGTTCACCGTCGCGCCCGCCGGACACGGGCAGGCCGCGATCTGGTACATGCAGCAGCTGTCGCCCGACGGGGTCGCCTACAACCTCATGTGCGCCGCGCGGATCCGCGGCCCCGTGGACGAACAGGCGCTGGAGAGGGCCGTGGCCGCGGTGGTGGAACGCCACCCCGCGCTGCGCACCTCCTTCGCCGAGGCCGGCGGACGCCCCCACCAACTGGTCTGGGCGGACCCCGTGTACGAGTTCCTGACCGAGGACGCCTCCGGCCTCGACGACGAGGCGGTGCTCGACCTCCTCGTCGACCACGGCCACCAACCGCTCGACCTCGACCAGGGCCCCGTCTTCCGGGTGGCGCTGGTGTCCCGGGGACCGGAGGACCACCATCTGCTGCTGGTGATCCACCACATCGCGGCCGACGCGGCGTCCGTCGACGTCGTCGTGCACGACCTGCGGGAGTTCTACGCGCAGGCCCTGCACGACGACCTCGGGCCGCAGGAGGCCGTGGCCCCCTACACCGACTTCGTCGCCTGGGAACAGCGGTGGCTCGCCGGGCCCCGCGCCCAGGAGGCACTGCGCTGGTGGACGGAGAGCCTGGCCGAGCCGCCCGCTCATCTCGACCTGCCGTCCGAGCCCGGCCCGGCGGCCCCGCCGGGCGTGCGGCCGCCGGGAGTCAGCTACGAGGGCGAGGACCTGACGTTCCGCTGGGACGCCGACGACACGCGCCGGCTCAAGGAGTTCGCGGCCCGCGAAGGGGTCTCCCTCAGCACGCTCCTCATGGCGGGCTTCTTCGCCACGCTCAACCGGTACGCCGGCGCCCAGGACGCCGTGGTCGCCACGGCCGTCGCCCAGCGCGGGGAGGCGGGCCGGGAGGCGGCGGTCGGCTACTACCTCAACACGGCACTCGTCCGCGCCAGGCCGACGGACGGCATCGGCTTCCGCGGGCTGCTGAAGGAGGTCCACGCGTACTCGCTCGGAATGCTGGAACACATGGACTACCCCCTGGACCTGCTGGCGCGGGAGCTGAACCCGCCCCGGGCCGACGGACGCTCCCCCTGGTTCGACTTCGCCGTCAACTGGCTGTCCGGCGACGCCTTCACCTACGCCACCACGCTGTTCCACGGCGTGGGCGAGCCCGAGGAACCCACCGGGGCACTCCCCATGGTTCCCGTCCCGCTGCGCCGGCACATCGCGAAGTTCGACCTGGAGATCACCATGGCCGACGTCGCGGACGAGGTCGTCGGCCAGGTCCAGTACAAACCCGGCCTCATGGAAAGGGAAACCGTGACGACCTTGCTGGAGTGGTTCCGCTCCGTGCTCCTGACGTCGATCGACCGACCGGACACACCACTCGCACTGCTGCCCCCGGTCCTCGTCGCGAAGGGAAGCGCGCTGTGA	MHSSGLDSAKAVQLVTALSEFLGRPVPVTALWDHPTPEALCRALAGDPQDEDTGGGRTRRGYDPQEPVALVGIGCRFPGAPDPESYWRLLVEGRDAVDVVPPVRRERIGPDDVAPSFRWGGHLDDIDLFDPLFFGISPREAVAMDPQQRLVLELGWEALEDAGIPPRSLAGSDTGVFMGSSWSDYAALAHRSATQEDIGPHTATGTQDSIIAGRLSYVLGLQGPSMAVDTACSSSLVAVHLACQSIRGGESELALAGGVNLSFLTEHFLAMDRLGALSSDGRIKAFDARADGAVRSEGAAVVVLAPLRTALERGLPVYCVIRGSAVNNDGLSNGLTAPNPRAQEALLRTAYRRSGIAPELVDYVECHGTGTPLGDPIEAKALGTVLGQGRDPGDPLRIGSVKTNLGHLEPAAGIAGLVKVALALRNGVLPASLHYTSPNPRIPFAEAGLRVQDRTAPWPRRADGRRAGVSAFGFGGTNCHVVTEELPRPEASLLLLSEDSRQALDDRVAELAADLADGTGTHLPALCREALDTRGTGPFRLAATAADRDELRAQLAAFTAERDHAGLVHRETGTRPPRVAFLFSGTGSQWLGMGRRLLAGMPAFRTSLTRVDARIREVADFSVLDELLAGPDRARLDDMEVVQPVLFAVQIALADAWRSLGVVPDVVLGQSIGEFAAAHVAGALGLDDAVRLAVHHARLVQRHAVGLGDAMVVDCDETRLAPHLAALADHVTLAGRNSPGSVLVSGDGTRLRELAARLTADGVTSHPVRMGYAAHSPLVEAVVAPLRTALAGITPAEPRIPMISTVTGERITGETVVGPDYWARNVRGESRLLDALLTTADHGVDAMIEISPHPVLLKPVRETLADRPISCLPSMRRGTDDARSLLSSLGELHAAGLTVAADSFLVGDRGRHVTPVRRGAPTRAVPEPEPADTHLVPVTAHSADALLDTCRALSRHVERDTGLTVPDLAHTLAARRSHHRHRVAILAGGRQELLDTLARVATGEPDPAVLRGATADGDHRRVAFVFSGSATQWPGMGRELLKRHAGFGAAMEECDAAVREVAGWSVLEELLAPAETSRLHEGDIQQPVLFALHVSLARLWTDLGVRPAALVGHSLGEVAAACVGGALSLEDGARIAVARSRLIQHEVGPGAMIVAEQSPELSACLARYEGEVSVAAYNSPTGVALSGTPEAIRALEADLKRAGLSSRALRVERAGHSVLMEPVLPALRAELKDITPRPFRVPLRSTALDAVVNPRVDADYWVRNLREPVRFSQAVAALVEDGIDTYVEIGPHGTLRGAIEETALSRGASVHVVDSLRRGQSDVRSVLGSVASLFTHGVPLTWDTLYPAGAQAVETPLVRWQKQRYWLGTTAAPRERGADVGAAPGAAVEEPAVPTGSREPRDVVLGEIAEMLAVPADLLGPTARLQDFGLDSMLAIRLTNRMQTLFGHRVSPVEFLKGGTVGELLDRVLTLVAPRSETPRPGTAPDDADPRPAHLTDDDAAELLDELVARGLLAPAEDGTPASEALRTALEKDRTFTVAPAGHGQAAIWYMQQLSPDGVAYNLMCAARIRGPVDEQALERAVAAVVERHPALRTSFAEAGGRPHQLVWADPVYEFLTEDASGLDDEAVLDLLVDHGHQPLDLDQGPVFRVALVSRGPEDHHLLLVIHHIAADAASVDVVVHDLREFYAQALHDDLGPQEAVAPYTDFVAWEQRWLAGPRAQEALRWWTESLAEPPAHLDLPSEPGPAAPPGVRPPGVSYEGEDLTFRWDADDTRRLKEFAAREGVSLSTLLMAGFFATLNRYAGAQDAVVATAVAQRGEAGREAAVGYYLNTALVRARPTDGIGFRGLLKEVHAYSLGMLEHMDYPLDLLARELNPPRADGRSPWFDFAVNWLSGDAFTYATTLFHGVGEPEEPTGALPMVPVPLRRHIAKFDLEITMADVADEVVGQVQYKPGLMERETVTTLLEWFRSVLLTSIDRPDTPLALLPPVLVAKGSAL	MNIMPISESQLSDWLALRSLLWPDHDDAHLLEMHQLLKQTDTLQLLAYTDSQQAVAMLEASIRHEYVNGTQTSPVAFLEGIYILPEYRRSGIATQLVQYVEEWAKQFACTEFASDAAIDNTISHAMHRALGFHETERVVYFKKNIG	1367.81	gnl|BL_ORD_ID|1787|hsp_num:0	1939			177	303	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000971.1|Cinnabaramide_17 # 21692 # 23530 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=CGA;rbs_spacer=13bp;gc_cont=0.737	BGC0000971.1|Cinnabaramide_17 	21692	23530	+	Loose	1000	137.117	almE	25.36	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAACACCCTGCACGGCAGGTTTCTCGAACACGCCGCGCTGACCCCGCGCACGCCGGCGCTCTACACCGACGCGGGCGTCATGACGTACGGGGAACTCGACCGGCGTTCGGCGCTGCTCGCCGAGCGGCTGATGCTCCGGGGCGCGGGCCCCGGCGTCGTCGTCGGCATCTGCGCCGAGCGCACCGAGAACCTGCTCGTCGGCATCCTGGGCATCCTGCGCGCGGGCGCCTGCTACCTGCCCCTCGACCCCAAGTACCCCGAGGAACGGCTCCACTTCATGGTGGAGGACAGCGGCACCCGGCTGCTGCTGACCACGTCCACGGCGCGCGACCGCTGCCCGCAGGGCCCCACCGTGCTCCTCCTCGACGACGGCACGGACGACCCCGCGCCCGCCGCCCCCCGTCCTCGGGCCACCCTCCCGGACGACACCGCCTACGTCATCTACACCTCCGGCTCCACCGGACGGCCCAAGGGCGTCGCGATCCGGCACGGCAGCTGCGCGGCCATGCTCGACGAGACCGACCGGATCTTCGCGGAGTGCGACCTGAGCGGGGTCGCGGCCGTCAGCTCCGTCTGCTTCGACCTCGCCGTGATGGAGATCTTCGCCCCGCTGTCCCGGGGCGGTGCCGTGATCCTGGTGGACAGCGCCGTCCACCTGCCCGAGAGCCCGCACCTGCACCGGGTGACCCACCTCAACACCGTCCCCTCGGTGATGGCGGGCCTGCTCGACGCGGGCGGCCTGCCCCCCTCCCTGCGGTCCGTGGTCCTCGGCGGGGAGGCGGTACGGCGCCGGCTCGTGGACCGGGTGTACCGGGAGACGAGCGCCGAGCGGGTCTTCAACGGATACGGCCCCACCGAGGGAACCGTCTTCTGCACCTTCAAACTGGTCCCGCCGGACGAGGACGGCGAGCCCTCCATCGGCACCCCCTCCGCCACGGCCCGCCTCTACGCTCTGGACGAGGAGCTGCGCCCCGTCCCCGAGGGCGAACCCGGGGAGCTGTACCTGGCGGGCAAGGGCCTGGCCTGGGGGTACGTCAACCGCCCCCGGCTGACGGCGGAACTCTTCGTGCCGGACCCGTACGCGGACGGCGAGCGCATGTACCGCACCGGGGACGTCGCCCGTGTCCTGCCCGGCGGCGAACTGGAGTTCGTCGGACGCGCCGACCACCAGGTGAAGGTGCGCGGCTACCGCATCGAACTCCAGGAGGCCGAGGCGTGGCTGTCCGGCTGCCCCGAGGTGAAGGAGGCGGCGGTCGCGGTGCACGGGGACGCGCTCGTGGGCTACGTCGTGCCGAGCGAACCCCCGGCCGGGCGGGAGGCGGAGACCGGGCCCTGGCTCGACGCCGCCCTCCAGGCCGGGATCACCGGGCGGCTGGCGGAGACCCTGCCCGACTACATGGTCCCCGAGACGGTGGTCTTCCTCGCCGAACTCCCCGTCTCGCCCAACGGCAAGCTCGACCGCGCGGCGCTGCCCGAACCCCCGGCGCCCCTCGCGCCGCGGACGCAGCAACCGCCCACCAGTCCCACGGAGCTGGCGCTCGCCGAACTCTGGGGCGAACTCCTGGACCGCGAGCCGGGGACCATCGGCGTCCGGGACGCCTTCTACGACCTCGGCGGGAACTCCCTGCTGCTGGTGCGGCTCGCCAAGCGGATGAGCCAGCGGTTCGACAGGCGGGTGGGGGTGTCGGACCTCTTCAGGTTCCGGGACATCGCCTCACTCGCCGAGTGGCTGGACGACAGCCGACAGGACACCACGCCCGACGCGGTCACGGAGGCCAGGCGCCGCGCAGAGGCCCGCCGCTCCGCGGTCCGCCGCGGCCGCCCGACCAGCGGCTGA	MNTLHGRFLEHAALTPRTPALYTDAGVMTYGELDRRSALLAERLMLRGAGPGVVVGICAERTENLLVGILGILRAGACYLPLDPKYPEERLHFMVEDSGTRLLLTTSTARDRCPQGPTVLLLDDGTDDPAPAAPRPRATLPDDTAYVIYTSGSTGRPKGVAIRHGSCAAMLDETDRIFAECDLSGVAAVSSVCFDLAVMEIFAPLSRGGAVILVDSAVHLPESPHLHRVTHLNTVPSVMAGLLDAGGLPPSLRSVVLGGEAVRRRLVDRVYRETSAERVFNGYGPTEGTVFCTFKLVPPDEDGEPSIGTPSATARLYALDEELRPVPEGEPGELYLAGKGLAWGYVNRPRLTAELFVPDPYADGERMYRTGDVARVLPGGELEFVGRADHQVKVRGYRIELQEAEAWLSGCPEVKEAAVAVHGDALVGYVVPSEPPAGREAETGPWLDAALQAGITGRLAETLPDYMVPETVVFLAELPVSPNGKLDRAALPEPPAPLAPRTQQPPTSPTELALAELWGELLDREPGTIGVRDAFYDLGGNSLLLVRLAKRMSQRFDRRVGVSDLFRFRDIASLAEWLDDSRQDTTPDAVTEARRRAEARRSAVRRGRPTSG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	110.07	gnl|BL_ORD_ID|4935|hsp_num:0	5928			51	1644	colistin A; colistin B
BGC0000971.1|Cinnabaramide_19 # 25399 # 26643 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.703	BGC0000971.1|Cinnabaramide_19 	25399	26643	+	Loose	500	28.8758	CARB-52	40.48	3005586	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	ATGAACTCTTCCGCCACCGACACCCTCGACCTCGCCGACCCCGCCACCTTCGCCGACCACGACCTCACCGACTTCTGGCGCCGGCTGCGCGACACCGCACCCGTGCACTGGAACCCGCCGACGGGCGAACGCGCCGGGTTCTGGGTGCTCTCCCGGCACGAGGACATCATGGCCGTCCACCGTGACGACGAGAACTTCACCTCCGAGCGCGGCAACGTCCTCGTCACCCTGCTGGAGGGCGGTGACGCGGGCGGCGGCAAGATGCTCGCGGTCACCGACGGGCCGCGTCACGAACAACTGCGCAAGATCCTGCTGAGATCGCTCGGTCCCCGGGTCCTCGCGCCCGTCGCCGCCGCCGTCCGGGCCAACACCCGTCGGCTGGTGCGGGAGGCGGTGACGCGGGACGAGTGCGACTTCGCCCTGGAGATCGCCAGCCGCATCCCGATGAACACGATCTCCAACCTGCTGGGCGTGCCCGAGAGCGACCGCGACTTCCTGCTGGCCCTGAACAAGGCGGCGCTCAGCGCCGACGACGACAGCGTCGACGAGGAGGAGTCGGCCGTCGCGCGCAACGAGATCCTGCTCTACTTCCTGGACCTGGTCGAGGAGCGGCGCAGGTCCCCGGGCGAGGACCTGATCAGCATCCTGGCGCACAGTGAGGTCGACGGCGTCCGCCTCAGCGACGAGGACGTCGTCCTCAACTGCTACAGCCTCATCATCGGGGGCGACGAGACCAGCCGGCTCACCATGATCGACAGCGTCTACTCCCTGGCCGCCCACCCCGACCAGTGGCGGCGGCTGAGAAACGGGGAGTGCGCGATCGACACGGCCGTCGACGAGGTGCTGCGCTGGGCGTCGCCGTCCATGCACTTCGGCCGGAGCGCGGTGCGCGACACGGAGGTGCGCGGCGTGCGCATCGCCGAGAACGACATCGTCACGCTGTGGCACTCCTCCGCCAACCGTGACGAGCGGGTCTTCGACCGGCCCGAGGTGTTCGACCTGGGCCGCACGCCCAACCGGCACGTCTCGTTCGGCTACGGCCCCCACTACTGCGTCGGCTCCTACCTGGCCAAGGTCGAGATAGCCGAACTGCTCACGGCCCTGCGGGACCTGACGACGGGGTTCGAGCGCGTCGGCGAGGCGCCGCGGGTCCGCTCCAACCTGCTGAACGGCTTCCACAGCCTGCCCGTCCGTTTCCACCCGGACCCCGCGGGCCTCGCCCGCGACGACGACCGGACGGAGTGA	MNSSATDTLDLADPATFADHDLTDFWRRLRDTAPVHWNPPTGERAGFWVLSRHEDIMAVHRDDENFTSERGNVLVTLLEGGDAGGGKMLAVTDGPRHEQLRKILLRSLGPRVLAPVAAAVRANTRRLVREAVTRDECDFALEIASRIPMNTISNLLGVPESDRDFLLALNKAALSADDDSVDEEESAVARNEILLYFLDLVEERRRSPGEDLISILAHSEVDGVRLSDEDVVLNCYSLIIGGDETSRLTMIDSVYSLAAHPDQWRRLRNGECAIDTAVDEVLRWASPSMHFGRSAVRDTEVRGVRIAENDIVTLWHSSANRDERVFDRPEVFDLGRTPNRHVSFGYGPHYCVGSYLAKVEIAELLTALRDLTTGFERVGEAPRVRSNLLNGFHSLPVRFHPDPAGLARDDDRTE	MKLLLVFSLLIPSMVFANSSKFQQVEQDAKVIEASLSAHIGISVLDTQTGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGEINPKSTIEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNAAANIILNALGGPESVTDFLRQIGDKETRLDRIESELNEGKLGDLRDTTTPNAIVNTLNELLFGSTLSQDGQKKLEYWMVNNQVTGNLLRSVLPEGWNIADRSGAGGFGARSITAVVWSEAQSPIIVSIYLAQTEASIADRNDAIVKIGRSIFEVYSSQSR	143.75	gnl|BL_ORD_ID|3367|hsp_num:0	4436			315	441	
BGC0000971.1|Cinnabaramide_20 # 26648 # 27481 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.734	BGC0000971.1|Cinnabaramide_20 	26648	27481	+	Loose	600	40.817	EstT	23.58	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGCCGTTCGTGACGGCCGGCGGGACCCGGCTGCACTACGAGTGCCACGGCTTCGGCGAACCGGTCGTGCTGGTCGCCGGGGCGGGCGCCTCCGGAACGTCGTGGCTGCCGTACCAGGTGCCCGCCCTCGTCGAGGCCGGCTACCGGGCGTACGTCTACGACTCCCGGGGCATCCCGCCGAGCGACGAGTGCCCGCAGGGGTTCGAGGTGACGGAGCTCGCCGCGGACCTGGCCGCCCTGACCGAACACCTCGCGACGGAACCGGTCCGGATGGTCGGCACCTCGATGGGCGCCCACGTCGTCCAGGAACTCGCGCTCGCCAGGCCCGACCTGGTCCGGCGGGCGGTGCTGCTGGCCGGCCGCGCCCGCTCGGACCCGCTGCGGGCCCACCTGGCCCTGGCCGACGTCGAACTCGGCGACTCGGGCGTGAACCTCCCCCCGGCCTACCGCGCGGCGGTGCGCGCCCTGCAGATGCTCTCGCCCCGCACGATGGACGACGAGACGGAGATCCAGGACTGGCTCGCGCTCTTCGAGCGTGAACCGCCCCCCGGCCCCGGTGTCCTGGCCCAGCTGGCGCTCCAGCCGATGCCCGACCGGCGCGCCGCCTACGCGGACATCACCGTGCCGTGCCACGTGATCTCGTTCGCCCACGACCTGGTCGCCCCGCCCCGGTACGGCCGCGAGCTCGCCGACAGCATCCCCGGCGCCACGTTCGACCTCGTCGACGACGCGGGGCACTTCGGGTACCTGGAGCAGCCGGACACCGTCAACAAGATCATTTCAAGGTACTTCGCGCTCGCGGACACCCGCGACGGGAAGACCTCGTGCCCCTGA	MPFVTAGGTRLHYECHGFGEPVVLVAGAGASGTSWLPYQVPALVEAGYRAYVYDSRGIPPSDECPQGFEVTELAADLAALTEHLATEPVRMVGTSMGAHVVQELALARPDLVRRAVLLAGRARSDPLRAHLALADVELGDSGVNLPPAYRAAVRALQMLSPRTMDDETEIQDWLALFEREPPPGPGVLAQLALQPMPDRRAAYADITVPCHVISFAHDLVAPPRYGRELADSIPGATFDLVDDAGHFGYLEQPDTVNKIISRYFALADTRDGKTSCP	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	90.52	gnl|BL_ORD_ID|4956|hsp_num:0	5948			81	450	tigecycline
BGC0000971.1|Cinnabaramide_21 # 27492 # 28838 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.707	BGC0000971.1|Cinnabaramide_21 	27492	28838	+	Loose	660	53.9138	MexS	25.67	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCAGCTTGTCCCGAGCCGTACTGGACGGCGCGTCGGCCGCGGAGATCGAGGCCGCCCCGGTGCCCGACACCTACCTGGCCCTGCACCTGCGGGCCGAGGACGCCGACATGTTCAAGGGGGTGGCCGACAAGGACGTCCGCAAGTCGCTCCGCCTCGGCGAGGTGCCCATGCCGGAGCTCGCGCCGGACGAGGTCCTCGTCGCGGTGATGGCCAGCTCCATCAACTACAACACGGTCTGGTCGGCGATGTTCGAGCCGATCCCGACCTTCCACTTCCTCAAGCAGAACGCCCGGCAGGGCGGCTGGGCGACCCGTCACGACCAGCCCTACCACGTGCTCGGCTCGGACTGCTCCGGCGTCGTGGTACGCACCGGCATCGGCGTACGGCGCTGGAAGCCCGGCGACCACGTCATCGTCCACCCCGCCCACGTCGACGAGCAGGAGCCCGCCACCCACGGCGACGGCATGCTCGGCACCGAACAGCGGGCCTGGGGCTTCGAGACCAACTTCGGCGGCCTGGCCGAGTACGGCGTGGTCCGGGCGAGCCAACTGCTGCCCAAGCCCGCCCACCTGACGTGGGAGGAGGCCGCGGTCAGCCCGCTGTGCGCCGGAACCGCCTACCGGATGCTCGTCAGCGACCGCGGAGCCCAGATGAAGCAGGGCGACATCGTCCTGATCTGGGGTGCCTCCGGGGGCCTCGGCTCGTACGCCATCCAGTTCGTCAAGAACGGCGGCGGCATCCCGGTGGCCGTCGTCAGCTCCGCGCAGAAGGAGGCGGCGGTGCGCGCCCTGGGCTGCGACCTGGTGATCAACCGCGCCGAGCTGGGCATCACCGACGACATCGCCGACGACCCCCGGCGCGTGGTCGAGACCGGCAGGAAGCTGGCCAAGCTGGTCGTCGAGAAGGCCGGCCGGGAACCGGACATCGTGTTCGAGCACACCGGTCGCGTCACCTTCGGGCTCTCCGTCATCGTGGCCCGGCGCGGCGGCACCGTGGTGACCTGCGGATCCAGCTCCGGCTACCTGCACACCTTCGACAACCGGTACCTGTGGATGAAGCTCAAGAAGATCGTCGGCAGCCACGGAGCCAACCACGAGGAGCAGCAGGCCACCAACCGGCTGTTCGAGAGCGGCGCCGTCGTCCCGGCGATGTCGGCCGTCTACCCGCTCGCCGAGGCCGCCGAGGCGTGCCGGGTCGTCCAGACCAGCCGGCAGGTCGGCAAGGTCGCGGTGCTCTGCATGGCACCGGAGCAAGGACTCGGAGTGACCGACCCCGACCTGCGCGCACGGCTGGGGGAGGACCGGCTCAACCCGCTGCGCGGTCTCACCGCCACCTCCCGGTGA	MSSLSRAVLDGASAAEIEAAPVPDTYLALHLRAEDADMFKGVADKDVRKSLRLGEVPMPELAPDEVLVAVMASSINYNTVWSAMFEPIPTFHFLKQNARQGGWATRHDQPYHVLGSDCSGVVVRTGIGVRRWKPGDHVIVHPAHVDEQEPATHGDGMLGTEQRAWGFETNFGGLAEYGVVRASQLLPKPAHLTWEEAAVSPLCAGTAYRMLVSDRGAQMKQGDIVLIWGASGGLGSYAIQFVKNGGGIPVAVVSSAQKEAAVRALGCDLVINRAELGITDDIADDPRRVVETGRKLAKLVVEKAGREPDIVFEHTGRVTFGLSVIVARRGGTVVTCGSSSGYLHTFDNRYLWMKLKKIVGSHGANHEEQQATNRLFESGAVVPAMSAVYPLAEAAEACRVVQTSRQVGKVAVLCMAPEQGLGVTDPDLRARLGEDRLNPLRGLTATSR	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	132.15	gnl|BL_ORD_ID|1039|hsp_num:0	1041			45	1005	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000971.1|Cinnabaramide_22 # 28896 # 29930 # -1 # ID=1_22;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0000971.1|Cinnabaramide_22 	28896	29930	-	Loose	650	45.4394	adeL	27.48	3000620	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	CGGCAGCGCCTGCCGAGAACAAGGGATCCCCGCATGAGCACCCGGCCGGATTTCAGCCTCACCCAACTGCTGTACTTCGCCACCATCGCCGAGACCGAGAGCATCTCCGAAGCGGCGATGCGACTGCACGCGTCCCAGTCCGCGGTGTCCTCGGCCATGCAGCGGCTGGAGCGTCAGCTCGGCGTCCAGCTGCTGCTGCGCCAGCGCGCCAAGGGGGTCGTGCTGACGCCGAACGGGCGGCTGCTGCTGAACGACGTACGCAGGATCCTGCGGCAGGCCCAGGACCTGAAGGACTCCAGCAGCCTCCTCCAGGAGATGGCCACGGGCCACCTCGAAGCCGGATGCTGCAGCACGATCACGCCGTTCCTGATGCCCAGGTCCCTGGCCCGCATGGAGGTGGCGCATCCCAGGCTGCACGTGAGTGTGCACGACACGCAGACCCCCTTCGACCTGCTGCGCAACGGGGTGTGCGAACTGGTCGTGACCTACGGTTTCTCCTCTGCCGAGGACATCGTGTTCACGGAGCTGGCGACTCCCCCGCTGTCCGCGCTCGTCTCCGAGTCGCATCCGCTGGCGGGCGAGCCGAGTGCCTCGCTGGCCGACTTCACGGACCTGCCGCTGCTGATGCTGAGCCTGCCGCACACGGGCGCGCACCACGCCTACGCACAGCGGATCTTCGCGCACAGCGGGATTCCCATGCCCCGGGTGATCCACGCGACGGGGCTCGAATCGCTGCGCGGCCTGGTCAGCGCGGGGGTGGGCTTCATGCTCACCCACCAGCCGCACTCGGAGCACACCCTGGACGGGGGACGGGTCTCCCGGGTGCCCATCGCCGACGACCACCCCGCCCTGCCGATCGGGGTGCTGACGATGGCGGGCGTCCGCCCGAGCCGCCGGGCGGAGTTGTTCATCGACGCGCTGCGGGTGGCCGCCCGGCAGGTGTACGAGCCGGTACGTGGCGCGCTGTACGAAGTCGACGCGCCACCGCCCCCCGTCCGGCAGGTCCGCCCGCACCGGGTCCTCGGCCTGGCGTGA	RQRLPRTRDPRMSTRPDFSLTQLLYFATIAETESISEAAMRLHASQSAVSSAMQRLERQLGVQLLLRQRAKGVVLTPNGRLLLNDVRRILRQAQDLKDSSSLLQEMATGHLEAGCCSTITPFLMPRSLARMEVAHPRLHVSVHDTQTPFDLLRNGVCELVVTYGFSSAEDIVFTELATPPLSALVSESHPLAGEPSASLADFTDLPLLMLSLPHTGAHHAYAQRIFAHSGIPMPRVIHATGLESLRGLVSAGVGFMLTHQPHSEHTLDGGRVSRVPIADDHPALPIGVLTMAGVRPSRRAELFIDALRVAARQVYEPVRGALYEVDAPPPPVRQVRPHRVLGLA	MRVFNKVVETNSFSLAADSLGLPRASVTTTIQALEKHLQVRLLNRTTRKISLTPDGAVYYDRTARILADVADIESSFHDAERGPRGQLRIDVPVSIGRLILIPRLRDFHARYPDIDLVIGLNDRPVDLVGEAVDCAIRVGELKDSSLIARRIGTFQCATAASPIYLEKYGEPTSIEDLQKNHKAIHFFSSRTGRNFDWDFVVDDLIKSVSVRGRVSVNDGDAYIDLALQGFGIIQGPRYMLTNHLESGLLKEVLPQWTPAPMPISAVYLQNRHLSLKVKVFVDWVAELFAGCPLLGGTALPFDQKCEFACDKETGHEYTIRTLVEQHNIAEAYTLKT	102.08	gnl|BL_ORD_ID|2315|hsp_num:0	2654			9	399	tetracycline
BGC0000971.1|Cinnabaramide_18 # 23558 # 25348 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.724	BGC0000971.1|Cinnabaramide_18 	23558	25348	+	Loose	750	48.9062	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	23.88	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAACGACCACCCCGAGCGGGAACTCGACGAGAGCGACATCGCGATCATCGGCATCGCATGCCGTTACCCAGGAGCCGGCGACAAGGACCGGTTCTGGGAGAACCTCGTCGAGGGCCGCGAATCCATCACCTTCCTGCGCACGGAGGAGATCGAGGGCGACGAGTCGCTGCTGCACAATCCGTCGTACGTCAGGGCCTGCGCGCCGCTCGAAGGCTACGACGAGTTCGACCCGGCCGTCTTCGGGATCACCGACCGCGTCGCGACGCTGATGACCCCGGAGCACCGCCTCTTCCTGGAGAGCGTGTGGGACGTCCTGGAGGACGCCGGCTACGACCCGGACCGTGTCCGGGGCGAGGTGGGCATCTACTCGGGCGCCAACCCCATGACCCCCGCCCAGTACAGCTCACCGCCGGACTGGGCCTCGGTCGGCCCCGAGGTGATGGACCGCAGCAACTCCTGGTTCACGGACACCATGACCTCGAACGCCCTGTACTACCTCGGGCTCACCGGCGAGGCGGTCACCGTGACGGCGGTGTGCACCGGCTTCCACTACTCGGTCCACCTCGCCTGCCAGTCGCTGCTCATGGGGCAGACCGACATGGCCGTGGCCGGCGGGGTGATGGTGCGGCTCCCGCAACGCCGCGGCTACCTCTGGGAGGAGGGCCGCATCGGCTCCCGGGACGGGCACTGCCGTCCGTTCGACGCCCACGGCACGGGCACGCGGCTCGCCAGCGGTGTCGCGACGCTGCTGCTCAAGCCGCTGACGCAGGCCGTCGCCGACGGCGACCACATCTACGCCAGCGTCAAGGGCACCGCCATCAACAACAACGGTGCCAGCTCGGTCTCCTACGGCTTCGCCCAGCCCGAGCGGCTCAGCGCCTGCATCGCGGGCGCCATGGCCGTCGGCGGCGTGAGCCCGGACACCGTCGGTCTGTACGAGGCCAACACCTTCGGGCTGCCCATCACCGACGGCCTGGAGGTCCGCGCCGCGCACATGGCCTACGGCAACCACACCGGCACCACGTCCCTGGGGTCCGTCAAGGGCAACATCGGGCACGCGGGTGTGGCCGCCGGCGGCTCCGGCACCGTGAAGGCGGCGCTCTCGCTCTACCACCGCCGGCTCGTGCCGACGATCAACCTGACCGAGGTGGACAAGGATCTCGATCTCCCGAACACCCCCTTCGTGCCCCAGTGGGAAGGCGAGGACTGGGTCCCGAAGGCCGGCATCCGGCGCGCGGGCGTCACCGCGCTCGGAGGGGGCGGCTACAACGCCCACCTGGTGCTGGAGGAGCCGCCCGAGCTGCCCGAGCGGGAGCCCGAGGCCGCCGTGCCCCGGCTCGTCGCTCTCTCCGCCCTCGACGACCGCGGCCTCGCCCGGCGGCGCGTGGCGCTCGGGGAGTGGCTCGCCCGGCACCCGGACGCCCGGCTCGACGACATCGCCCTCAGCCTCAACCTGGGGCGCCGGATCATGGACCGGCGCTGGGCGTGCGTCGTCGCCACCACGGCCGAACTGGCCGAGGCGCTCAAGGCCGACACCGGCGACCGGGTCGCCTCCGGTGCCTCCGGGACCCACCTGGACCTGGAAGGACTGCGCACCACCGACGCCGGACTCGCCCCCGCCACCGCCGCCGCGCGGGACGACGAGGACACCCTGCGGCGGCTCGCCCGGGCGTGGACGCGCGGACAGGGGGTGGACTTCGCCGCACTGCACGAGGGCCTGCCCGGCCGCCGTGTCCCGCTGCCCGGCTACCCGTTCGCGCGCCGGCGCTTCTGGCGCACCCACTGGTGA	MNDHPERELDESDIAIIGIACRYPGAGDKDRFWENLVEGRESITFLRTEEIEGDESLLHNPSYVRACAPLEGYDEFDPAVFGITDRVATLMTPEHRLFLESVWDVLEDAGYDPDRVRGEVGIYSGANPMTPAQYSSPPDWASVGPEVMDRSNSWFTDTMTSNALYYLGLTGEAVTVTAVCTGFHYSVHLACQSLLMGQTDMAVAGGVMVRLPQRRGYLWEEGRIGSRDGHCRPFDAHGTGTRLASGVATLLLKPLTQAVADGDHIYASVKGTAINNNGASSVSYGFAQPERLSACIAGAMAVGGVSPDTVGLYEANTFGLPITDGLEVRAAHMAYGNHTGTTSLGSVKGNIGHAGVAAGGSGTVKAALSLYHRRLVPTINLTEVDKDLDLPNTPFVPQWEGEDWVPKAGIRRAGVTALGGGGYNAHLVLEEPPELPEREPEAAVPRLVALSALDDRGLARRRVALGEWLARHPDARLDDIALSLNLGRRIMDRRWACVVATTAELAEALKADTGDRVASGASGTHLDLEGLRTTDAGLAPATAAARDDEDTLRRLARAWTRGQGVDFAALHEGLPGRRVPLPGYPFARRRFWRTHW	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	143.27	gnl|BL_ORD_ID|1968|hsp_num:0	1943			471	1239	isoniazid
